July 29, 2024
BioHealth Capital Region Maintains #3 Ranking: Insights with GEN’s Alex Philippidis on BioTalk
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Alex Philippidis, Senior…
July 29, 2024
BioHealth Capital Region Maintains #3 Ranking: Insights with GEN’s Alex Philippidis on BioTalk
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Alex Philippidis, Senior Business…
July 26, 2024
Washington DC’s 60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
WASHINGTON, July 25, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new…
July 24, 2024
BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024
The BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has successfully retained its position as the #3 biopharma cluster in…
July 24, 2024
MedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance
RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD.…
July 24, 2024
Mirecule Wins MedCity INVEST 2024 Competition
Chicago, May 2024 — miRecule, a cutting-edge startup focused on developing antibody RNA conjugate therapeutics, clinched the top spot at…